Literature DB >> 7097122

Cholesteryl ester-rich microemulsions: stable protein-free analogs of low density lipoproteins.

D P Via, I F Craig, G W Jacobs, W B Van Winkle, S C Charlton, A M Gotto, L C Smith.   

Abstract

A method has been devised for the preparation of stable lipid microemulsions containing cholesterol, cholesteryl ester, phosphatidylcholine, and trioleoylglycerol in the relative molar ratios found in low density lipoproteins. Gel permeation chromatography showed these microemulsions to be essentially homogeneous with respect to chemical composition. Omission of triolein or substitution of a diunsaturated phosphatidylcholine for either a disaturated or monosaturated-monounsaturated phosphatidylcholine destroyed the observed homogeneity of the microemulsions. The particle diameter of the negatively-strained relative elution volumes of the cholesteryl ester-rich microemulsion, VLDL2, VLDL3, and LDL indicated a mean diameter of about 35 nm. The cholesteryl ester-rich microemulsion can be used as a cholesteryl ester donor for plasma protein-mediated transfer of cholesteryl ester to plasma lipoproteins and for studying apoprotein-lipid interactions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7097122

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  4 in total

1.  Preparation and use of lipid microemulsions as nutritional supplements for culturing mammalian cells.

Authors:  F J Darfler
Journal:  In Vitro Cell Dev Biol       Date:  1990-08

2.  Physicochemical characterization of protein-free low density lipoprotein models and influence of drug loading.

Authors:  A Gerke; K Westesen; M H Koch
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

3.  [3H]cholesterol transfer from microemulsion particles of different sizes to human fibroblasts.

Authors:  S Ekman
Journal:  Lipids       Date:  1987-09       Impact factor: 1.880

4.  Cholesterol improves the utilization of parenteral lipid emulsions.

Authors:  Wilfred Druml; Margot Fischer
Journal:  Wien Klin Wochenschr       Date:  2003-11-28       Impact factor: 1.704

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.